Robotic Angiography Systems Market Size & Share, by Technology (X-Ray, CT, MR Angiography Systems); Application (Coronary, Endovascular, Neuro, Onco-Angiography); Indication (Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure); End-user (Hospitals, Specialty Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4163
Published Date: Feb 17, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Robotic Angiography Systems Landscape

GE HealthCare Technologies Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

KUKA AG
Koninklijke Philips N.V.
Siemens Healthcare GmbH
Corindus, Inc.
Shimadzu Corporation
Boston Scientific Corporation
Abbott Laboratories
Canon Medical Systems Corporation
Medtronic Plc

Browse Key Market Insights with Data Illustration:

Robotic Angiography Systems Market Size Forecasts 2035

In the News

GE HealthCare Technologies Inc. announced that it has introduced the new Allia IGS 7 Platform for advancing precision medicine in image-guided therapies. This new platform, which has received the Red Dot Design Award for Product Design, provides its users greater flexibility, enabling full mobility in the workplace.
Koninklijke Philips N.V.’s healthcare division, announced the launch of a new hybrid of its spectral CT imaging technology, popularly known as the Spectral CT 7500 system, with its Angio CT suite, known as the Image-Guided therapy System – Azurion with FlexArm. This new technology would give interventionalists immediate table-side access to two key imaging modalities for performing both CT and angio guidance in one single room.

Frequently Asked Questions (FAQ)

Promising expenditure from hospitals for the adoption of advanced medical robotics to drive the market growth are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023-2035.

High cost of angiography procedures and robotic angiography devices is estimated to be the growth hindering factor for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are KUKA AG, Koninklijke Philips N.V., Siemens Healthcare GmbH, Corindus, Inc., Shimadzu Corporation, Boston Scientific Corporation, Abbott Laboratories, Canon Medical Systems Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by technology, application, indication, end-user, and region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Robotic Angiography Systems Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the robotic angiography systems market?

What would be the CAGR of robotic angiography systems market over the forecast period?

What are the challenges affecting the robotic angiography systems market growth?

Which region will provide more business opportunities for growth of robotic angiography systems market in future?

Who are the major players dominating the robotic angiography systems market?

How are the company profiles selected?

What are the segments in the robotic angiography systems market?

Which segment captures the largest market size in end-user segment in the robotic angiography systems market?